ANKTIVA

The provided summary is based on a recent conversation (likely a video interview) with Dr. Patrick Soon-Shiong, a renowned oncologist, biotech entrepreneur, and founder of ImmunityBio. Soon-Shiong has presented similar theses in several public appearances, including interviews with Tucker Carlson in March 2025 and posts on X. The claims are largely plausible and supported by scientific literature where verifiable. However, they represent a mix of established facts, preliminary observations, and speculative hypotheses. The specific study on COVID-19 and p53 inhibition, conducted with Dr. Carlos Cadona, has not been published by November 2025. Soon-Shiong describes it as “soon to be published,” indicating ongoing research but not yet providing peer-reviewed evidence.